GenoFocus Inc Asset Resilience Ratio
GenoFocus Inc asset resilience ratio. GenoFocus Inc (187420) has an Asset Resilience Ratio of 16.26% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read GenoFocus Inc total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of GenoFocus Inc (2014–2024)
Asset resilience ratio of GenoFocus Inc from 2014 to 2024. This chart shows how GenoFocus Inc's Asset Resilience Ratio has changed over time. See GenoFocus Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down GenoFocus Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is GenoFocus Inc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩22.00 Billion | 16.26% |
| Total Liquid Assets | ₩22.00 Billion | 16.26% |
Asset Resilience Insights
- Good Liquidity Position: GenoFocus Inc maintains a healthy 16.26% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
GenoFocus Inc Industry Peers by Asset Resilience Ratio
Compare GenoFocus Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Brenntag SE
F:BNR |
Specialty Chemicals | 0.06% |
|
Xinjiang Daqo New Energy Co Ltd
SHG:688303 |
Specialty Chemicals | 4.33% |
|
China Hainan Rubber Industry Group Co Ltd
SHG:601118 |
Specialty Chemicals | 0.09% |
|
Bloomage Biotechnology Corp Ltd
SHG:688363 |
Specialty Chemicals | 0.70% |
|
Shen Ma Industry Co Ltd
SHG:600810 |
Specialty Chemicals | 0.06% |
|
Sudarshan Chemical Industries Limited
NSE:SUDARSCHEM |
Specialty Chemicals | 15.45% |
|
Suqian Unitech Corp. Ltd. Cl A
SHG:603065 |
Specialty Chemicals | 0.59% |
|
Sino-High (China) Co. Ltd.
SHE:301076 |
Specialty Chemicals | 17.25% |
GenoFocus Inc Asset Resilience Ratio by Year (2014–2024)
GenoFocus Inc asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for GenoFocus Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 57.30% | ₩83.81 Billion ≈ $56.79 Million |
₩146.26 Billion ≈ $99.12 Million |
+19.65pp |
| 2023-12-31 | 37.65% | ₩36.84 Billion ≈ $24.97 Million |
₩97.86 Billion ≈ $66.32 Million |
+6.62pp |
| 2022-12-31 | 31.03% | ₩41.55 Billion ≈ $28.16 Million |
₩133.91 Billion ≈ $90.75 Million |
+9.41pp |
| 2021-12-31 | 21.61% | ₩25.61 Billion ≈ $17.36 Million |
₩118.52 Billion ≈ $80.32 Million |
-9.79pp |
| 2020-12-31 | 31.40% | ₩35.56 Billion ≈ $24.10 Million |
₩113.23 Billion ≈ $76.73 Million |
+6.71pp |
| 2019-12-31 | 24.69% | ₩22.27 Billion ≈ $15.09 Million |
₩90.20 Billion ≈ $61.13 Million |
+11.54pp |
| 2018-12-31 | 13.16% | ₩9.25 Billion ≈ $6.27 Million |
₩70.33 Billion ≈ $47.66 Million |
-18.24pp |
| 2017-12-31 | 31.39% | ₩22.02 Billion ≈ $14.93 Million |
₩70.15 Billion ≈ $47.54 Million |
-55.05pp |
| 2016-12-31 | 86.44% | ₩54.65 Billion ≈ $37.04 Million |
₩63.23 Billion ≈ $42.85 Million |
+83.64pp |
| 2015-12-31 | 2.80% | ₩856.00 Million ≈ $580.10K |
₩30.52 Billion ≈ $20.69 Million |
+2.41pp |
| 2014-12-31 | 0.39% | ₩66.00 Million ≈ $44.73K |
₩16.94 Billion ≈ $11.48 Million |
-- |
About GenoFocus Inc
HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phy… Read more